Microbiologics recalled the KWIK-STIK quality control kit on November 13, 2025. The recall affects five units that may have incorrect labeling. This issue may compromise the accuracy of culture media testing for Vibrio parahaemolyticus.
Some products packaged for lot 818-111-7 may have been packaged in pouches labeled as lot 857-53-10.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Microbiologics Inc or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is the KWIK-STIK quality control kit for culture media, catalog number 0818K. The potentially affected lot number is 818-111-7. The product distributed internationally includes countries such as UAE, China, Singapore, and Kazakhstan.
The recall stems from products packaged under lot number 818-111-7 that may have been incorrectly labeled as lot number 857-53-10. This mislabeling poses a high hazard risk as it could lead to inaccurate testing results.
No specific incidents or injuries have been reported in connection with this recall. The potential for misdiagnosis or incorrect culture results remains a concern.
Stop using the recalled quality control kit immediately. Follow the recall instructions provided by the manufacturer. Contact Microbiologics Inc or your healthcare provider for further instructions.
For more information, call Microbiologics Inc at 1-800-XXXX-XXXX or visit their website at www.microbiologics.com.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.